rss
Postgrad Med J 2002;78:465-468 doi:10.1136/pmj.78.922.465
  • Review

Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when?

  1. M P Jones
  1. Correspondence to:
 Dr Michael P Jones, Director, Gastroenterology Laboratory, Northwestern University/Northwestern Memorial Hospital, Galter Pavilion 4–103, 251 E Huron Street, Chicago, IL 60611, USA;
 mpjones{at}nmh.org
  • Received 6 February 2002
  • Accepted 27 May 2002

Abstract

For patients with suboptimal relief from lifestyle modifications, acid suppressive therapy remains a cornerstone of treatment for gastro-oesophageal reflux disease (GORD). While a great deal of attention is focused on complications of GORD, adequate symptom relief remains an important and practical therapeutic goal. Adequate symptom relief is an achievable and easily measurable endpoint that both restores quality of life and prevents many potential complications.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.